Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 1
2003 1
2008 1
2009 2
2010 4
2011 1
2012 2
2013 1
2014 6
2015 7
2016 3
2017 3
2018 3
2019 1
2020 1
2021 5
2022 2
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

40 results

Results by year

Filters applied: . Clear all
Page 1
High-dose radiotherapy and risk-adapted androgen deprivation in localised prostate cancer (DART 01/05): 10-year results of a phase 3 randomised, controlled trial.
Zapatero A, Guerrero A, Maldonado X, Álvarez A, San-Segundo CG, Rodríguez MÁC, Solé JM, Olivé AP, Casas F, Boladeras A, de Vidales CM, de la Torre MLV, Vara S, Sanz JL, Calvo FA. Zapatero A, et al. Among authors: boladeras a. Lancet Oncol. 2022 May;23(5):671-681. doi: 10.1016/S1470-2045(22)00190-5. Epub 2022 Apr 12. Lancet Oncol. 2022. PMID: 35427469 Clinical Trial.
Patient-reported outcomes after treatment for clinically localized prostate cancer: A systematic review and meta-analysis.
Ávila M, Patel L, López S, Cortés-Sanabria L, Garin O, Pont À, Ferrer F, Boladeras A, Zamora V, Fosså S, Storås AH, Sanda M, Serra-Sutton V, Ferrer M. Ávila M, et al. Among authors: boladeras a. Cancer Treat Rev. 2018 May;66:23-44. doi: 10.1016/j.ctrv.2018.03.005. Epub 2018 Apr 3. Cancer Treat Rev. 2018. PMID: 29673922 Review.
Predictive factors for abiraterone withdrawal syndrome.
Almendros S, Berenguer-Francés MA, Ferrer-González F, Boladeras A, Guix I, Guedea F. Almendros S, et al. Among authors: boladeras a. Actas Urol Esp (Engl Ed). 2019 Jul-Aug;43(6):300-304. doi: 10.1016/j.acuro.2019.01.003. Epub 2019 May 3. Actas Urol Esp (Engl Ed). 2019. PMID: 31060755 English, Spanish.
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study.
Suárez JF, Zamora V, Garin O, Gutiérrez C, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Guedea F, Vigués F, Castells M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Suárez JF, et al. Sci Rep. 2022 Jul 22;12(1):12589. doi: 10.1038/s41598-022-16395-w. Sci Rep. 2022. PMID: 35869124 Free PMC article.
Five-year quality of life in patients with high-risk localized prostate cancer treated with external beam radiotherapy alone versus external beam radiotherapy with high-dose-rate brachytherapy boost: a prospective multicenter study.
Martínez E, Garin O, Pardo Y, Fernández P, Guix B, Gutiérrez C, Boladeras A, Ferrer F, Hernández T, Ayala A, Egiguren M, Fernández G, Muñoz V, Macías V, Pera J, Pont À, Ferrer M, Guedea F; Multicentric Spanish Group of Clinically Localized Prostate Cancer; Multicentric Spanish Group of Clincally Localized Prostate Cancer: Montse Ferrer, Àngels Pont, Olatz Garin, Yolanda Pardo, Jordi Alonso, Mónica Ávila, Víctor Zamora, Ferran Guedea, Montse Ventura, Cristina Gutiérrez, Ferran Ferrer, Ana Boladeras, José Francisco Suárez, Manel Castells, Xavier Bonet, Pastor S, Carmen Bonet, Gemma Sancho, Javier Ponce de León, Joan Palou, Belén de Paula, Alai Goñi, Pablo Fernández, Ismael Herruzo, Asunción Hervás, Alfredo Ramos, Víctor Macías, Josep Solé, Marta Bonet, Alfonso Mariño, Patricia Cabrera, Maria José Ortiz. Martínez E, et al. Among authors: boladeras a. J Contemp Brachytherapy. 2021 Feb;13(1):1-11. doi: 10.5114/jcb.2021.103580. Epub 2021 Feb 18. J Contemp Brachytherapy. 2021. PMID: 34025730 Free PMC article.
Prognostic value of testosterone castration levels following androgen deprivation and high-dose radiotherapy in localized prostate cancer: Results from a phase III trial.
Zapatero A, Álvarez A, Guerrero A, Maldonado X, González San Segundo C, Cabeza MA, Martín de Vidales C, Solé JM, Pedro Olivé A, Casas F, Boladeras A, Vázquez de la Torre ML, Vara S, Calvo FA. Zapatero A, et al. Among authors: boladeras a. Radiother Oncol. 2021 Jul;160:115-119. doi: 10.1016/j.radonc.2021.04.018. Epub 2021 May 5. Radiother Oncol. 2021. PMID: 33964325 Free article. Clinical Trial.
Intermittent versus continuous androgen deprivation therapy to biochemical recurrence after external beam radiotherapy: a phase 3 GICOR study.
Casas F, Henríquez I, Bejar A, Maldonado X, Alvarez A, González-Sansegundo C, Boladeras A, Ferrer F, Hervás A, Herruzo I, Caro M, Rodriguez I, Ferrer C. Casas F, et al. Among authors: boladeras a. Clin Transl Oncol. 2017 Mar;19(3):373-378. doi: 10.1007/s12094-016-1538-5. Epub 2016 Oct 21. Clin Transl Oncol. 2017. PMID: 27770397 Clinical Trial.
Multidisciplinary cancer care may impact on the postoperative mortality and survival of patients with oesophageal and oesophagogastric junction cancer: a retrospective cohort study.
Galán M, Farran L, Aliste L, Hormigo G, Aranda H, Bettonica C, Boladeras AM, Botargues JM, Calvo M, Creus G, De Lama ME, Gornals JB, Mast R, Miró M, Paúles MJ, Robles J, Virgili N, Borràs JM. Galán M, et al. Among authors: boladeras am. Clin Transl Oncol. 2015 Mar;17(3):247-56. doi: 10.1007/s12094-014-1221-7. Epub 2014 Dec 18. Clin Transl Oncol. 2015. PMID: 25520158
Treatment of localised prostate cancer with radiation therapy: evidence versus opinion.
Guedea F, Ramos A, Herruzo I, Sánchez Calzado JA, Contreras J, Romero J, Craven-Bartle J, Willisch P; SEOR (Spanish Society of Radiation Oncology); López Torrecilla JL, Maldonado X, Sancho G, Zapatero A; UROONCOR (Prostate Group of SEOR); Ferrer M, Pardo Y, Fernández P, Mariño A, Hervás A, Macís V, Boladeras A, Ferrer F; Multicentric Spanish Group of Clinically Localized Prostate Cancer; Davis BJ. Guedea F, et al. Among authors: boladeras a. Clin Transl Oncol. 2010 May;12(5):315-7. doi: 10.1007/s12094-010-0511-y. Clin Transl Oncol. 2010. PMID: 20466614 No abstract available.
40 results